The Effectiveness of Electroconvulsive Therapy on Catatonia in a Case of Anti-N-Methyl-D-Aspartate (Anti-NMDA) Receptor Encephalitis.

Autor:	Olaleye KT; Neurology, Tampa General Hospital, Tampa, USA., Oladunjoye AO; Psychiatry, Reading Hospital Tower Health, West Reading, USA.; Medical Critical Care, Boston Children's Hospital, Boston, USA., Otuada D; Psychiatry, Reading Hospital Tower Health, West Reading, USA., Anugwom GO; Psychiatry and Behavioral Sciences, West Oaks Behavioral Hospital, Houston, USA.; Psychiatry and Behavioral Sciences, Houston Behavioral Healthcare Hospital, Houston, USA., Basiru TO; Developmental Behavioral Pediatrics, Dell Children's Medical Center, Austin, USA., Udeogu JE; Public Health, Georgia Department of Public Health, Savannah, USA., Opaleye-Enakhimion T; Public Health, Greater Philadelphia Health Action, Philadelphia, USA., Espiridion ED; Psychiatry, Drexel University College of Medicine, Philadelphia, USA.; Psychiatry, West Virginia School of Osteopathic Medicine, Lewisburg, USA.; Psychiatry, West Virginia University School of Medicine, Martinsburg, USA.; Psychiatry, Philadelphia College of Osteopathic Medicine, Philadelphia, USA.; Psychiatry, Reading Hospital Tower Health, West Reading, USA.
Jazyk:	angličtina
Zdroj:	Cureus [Cureus] 2021 Jun 17; Vol. 13 (6), pp. e15706. Date of Electronic Publication: 2021 Jun 17 (Print Publication: 2021).
DOI:	10.7759/cureus.15706
Abstrakt:	Catatonia is a symptom seen in a variety of neuropsychiatric conditions, including anti-N-Methyl D-aspartate receptor (NMDAR) encephalitis. When associated with anti-NMDAR encephalitis, catatonia is resistant to standard therapy. However, electroconvulsive therapy (ECT) has shown promising success in management. This case report presents a 25-year-old African American female who presented to the emergency room with nervousness, sweating, insomnia, and visual and auditory hallucinations. She was treated symptomatically for anxiety but returned to the hospital after she continued to experience worsening symptoms. Her anxiety worsened, and she became more agitated, warranting an extensive workup, including magnetic resonance imaging (MRI) and electroencephalogram (EEG), which showed normal findings. She also had an anti-NMDA receptor antibodies titer done, which showed a positive titer result. She was treated with intravenous steroids, intravenous immunoglobulin G (IgG), plasma exchange, and rituximab, which did not improve her symptoms, and she was discharged home after a prolonged hospital stay. On follow-up visits, she reported worsening confusion, aggression, and suicidal behaviors. The patient was readmitted, during which she experienced catatonia and psychiatric symptoms, and her anti-NMDAR titer had increased to 1:1280. Further treatments with intravenous steroids, intravenous IgG, plasma exchange, and rituximab, including haloperidol and clonazepam, failed to improve her condition. However, her condition improved remarkably following treatment with 12 rounds of ECT. No randomized control trial has been done to demonstrate the effectiveness of ECT in the treatment of anti-NMDAR encephalitis despite various reports of the effectiveness of this treatment modality. This case report adds to the growing clinical evidence in support of the use of ECT in anti-NMDAR encephalitis patients with catatonia. ECT can be incorporated as standard protocol in the treatment of catatonia and associated psychiatric symptoms when managing a patient with anti-NMDAR encephalitis associated with catatonic features. Competing Interests: The authors have declared that no competing interests exist. (Copyright © 2021, Olaleye et al.)
Databáze:	MEDLINE
Externí odkaz:	Zobrazit plný text záznamu